Tag: data

AI-driven rapid profit impact analysis supports optimal decision-making KAWASAKI, Japan, July 3, 2025 /PRNewswire/ -- Fujitsu Limited today announced the launch of a new solution...

Honest Loans offers access to flexible online loan connections in 2025, supporting fast funding options for borrowers with less-than-perfect credit.

Honest Loans offers access to flexible online loan connections in 2025, supporting fast funding options for borrowers with less-than-perfect credit.

HONG KONG, July 4, 2025 /PRNewswire/ -- AsiaPay, a prominent provider of digital payment solutions in the Asia-Pacific region, announced today a partnership with...

Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater ChinaBrii Biosciences retains ex-Greater China rights to address the global antimicrobial...

Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater ChinaBrii Biosciences retains ex-Greater China rights to address the global antimicrobial...

SINGAPORE, July 4, 2025 /PRNewswire/ -- XL Ventures Pte Ltd, a Singapore-headquartered climate tech focused company, has received In-Principle Approval from the Monetary Authority...

SINGAPORE and VIENNA, July 4, 2025 /PRNewswire/ -- As a partner event of the Mayors Forum of the World Cities Summit 2025, the fourth...

ROAD TOWN, British Virgin Islands, July 3, 2025 /CNW/ - Aura Minerals Inc. (TSX: ORA) (B3: AURA33) and (OTCQX: ORAAF) ("Aura" or the "Company") announced...

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management.

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management.

As Bitcoin returns to the $100,000 mark and global demand for clean energy and remote computing services continues to grow, Find Mining, a long-established cloud mining platform founded in 2018, announced that it has officially launched a new one-stop multi-currency AI cloud mining solution and supporting mobile applications, committed to providing global users with a smarter, low-threshold, and sustainable way to increase the value of digital assets.

As Bitcoin returns to the $100,000 mark and global demand for clean energy and remote computing services continues to grow, Find Mining, a long-established cloud mining platform founded in 2018, announced that it has officially launched a new one-stop multi-currency AI cloud mining solution and supporting mobile applications, committed to providing global users with a smarter, low-threshold, and sustainable way to increase the value of digital assets.

SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating potential violations of federal and state securities laws by certain officers and directors of the following companies: Telephone and Data Systems, Inc. (NYSE: TDS), Fluence Energy, Inc. (NASDAQ: FLNC), The Bancorp, Inc. (NASDAQ: TBBK), Zynex, Inc. (NASDAQ: ZYXI). Long-term shareholders of any of these companies who have continuously held shares during the relevant time periods may be able to hold certain officers and directors personally accountable for misconduct and assist in reforming the company’s corporate governance.

-Record earnings increasing to $0.19 per share -Record operating income of $16.8 million, reflecting a 27% increase from prior year OLATHE, Kan., July 3, 2025 /PRNewswire/...

New 2025 At-Home Protocol Uses OTC Nerve Activation Tool to Reinforce Stability, Restore Confidence, and Help Reduce Fall Risk in Adults 60+

New 2025 At-Home Protocol Uses OTC Nerve Activation Tool to Reinforce Stability, Restore Confidence, and Help Reduce Fall Risk in Adults 60+

The GPRC5D-directed therapies market is witnessing robust growth, driven by the high unmet need in relapsed/refractory multiple myeloma. Innovative modalities like CAR-T cells, bispecific...